PCI Pharma Services’ Post

ESG-related challenges will take time to overcome in any industry. It's a continuous journey whereby achievements and milestones stand on the shoulders of previous accomplishments.   ESG must be woven into a business's fabric to obtain meaningful progress and tangible results, and several approaches can help. Technology adoption and innovation, including leveraging digitalization and automation trends to help cut energy consumption or material waste. Collaboration with other industries when it comes to complex supply chain processes and global reach — energy, packaging, and manufacturing, to name a few — to develop and hone best practices toward net-zero goals.   Read more from Dr. Kevin Robinson, Manufacturing Chemist, and Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, on tackling climate science, workforce empowerment, responsible waste management, and supply chain security.   https://lnkd.in/ex-3_MEX #ESG #Sustainability #LetsTalkFuture

Reports estimate that over 500 CDMOs are currently operating worldwide. However, only a small percentage can serve in a consultative capacity and perform non-core, value-added functions alongside the core functions of development and manufacture, clinical trial supply, and commercial packaging. The provision of non-core support services differentiates the good from the great. As the outsourcing landscape continues to evolve, sponsors should consider the impact of such services when developing their RFPs. By imbuing the RFP process with a wider consideration of the full scope of what the CDMO can offer, biopharma companies can maximize their chances of finding a CDMO partner that can provide seamless solutions and reduce vendor management complexity. Read our latest article, Support Services & the Holistic Approach to the RFP Decision-Making Process: https://lnkd.in/eP8eWq5A #CDMO #OutSourcing #BioPharma #LetsTalkFuture

The team behind pci | bridge™ is dedicated to our client's success while advancing the digital platform by offering real-time supply chain visibility across the PCI network.    With decades of collective experience in project management, product adoption, and pharmaceutical supply chain management, the team provides hands-on support to ensure clients maximize their data and receive a personalized experience. Utilizing client interaction and feedback helps the team consistently improve the platform with features to enhance the user experience. Recent feature rollouts have included integrations with Smartsheet and DocuSign, report enhancements, and improved order management. As we look forward to the next year, clients can expect to see new functionality added to pci | bridge™, boosting tracking and reporting features, and giving clients even more power and flexibility.   Learn More: https://lnkd.in/eS5c_fRK #ThePowerOfExperience #LetsTalkFuture #pcibridge.

Aimee Hodge of PCI Pharma Services recently spoke with Felicity Thomas, MChem, about how leveraging automation advancements in sterile fill-finish can help improve efficiency in aseptic processing and speed up the supply of critical drug products. Automating processes and bringing robotics into aseptic processing, together with single-use systems, is helping to streamline processes, minimizing human intervention and reducing the risk of errors or contamination. Read more In the recent edition of Pharmaceutical Technology on how advancements in automation and robotics are revolutionizing aseptic fill/finish processing: https://lnkd.in/e7GGx3HW #CDMO #SterileFillFinish #BioTech #LetsTalkFuture

With nearly two-thirds of the early-development pipeline coming from small and emerging biopharma, there is a great need to accelerate programs into clinical trials and secure additional funding. At the same time, companies are seeking to de-risk manufacturing operations. Robotic gloveless isolator sterile fill-finish systems address both of these needs.  Jerome Detreille, Derek Truninger, and Peter Kim from PCI Pharma Services met with Pharma's Almanac Editor-in-Chief, David Alvaro, to discuss how the company supports the accelerated timelines of its client partners by providing robotic isolator sterile filling capacity for vials, prefilled syringes, and cartridges at their San Diego, CA, facility to streamline clinical supply chains. Read the interview here: https://lnkd.in/eUQFV-wA #AsepticFillFinish #Robotics #CDMO #LetsTalkFuture

Ed Groleau and Henrik Schlieker of PCI Pharma Services spoke at yesterday's Science for Breakfast event in Medicon Village, Lund, Sweden.   They shared invaluable insights on how the PCI SMART FHD program stands out by offering faster, cost-effective drug development. By offering tailored services covering manufacturing, packaging, stability testing, and regulatory support, SMART FHD redefines efficiency. It streamlines the journey from drug substance to Phase I trials in just six months. With a promise of swift progression to market, authorization marks a transformative shift, setting a new standard for innovation and accessibility.   For more info on SMART FHD Program and Services: https://lnkd.in/gp-W5_QV  

The journey from early-phase clinical trials to successful commercial launch for an injectable drug product is complex and multifaceted. Choosing between a traditional vial or prefilled syringe and a modern autoinjector can significantly impact patient experience, adherence, and market competitiveness when considering the delivery system. In this article published by ONdrugDelivery, Jeff Clement and William Welch from PCI Pharma Services explore the emergence of parallel development as a strategic approach to expedite the development process and bring innovative therapies in drug devices such as autoinjectors to market faster. Providing insight in navigating key considerations such as drug product device compatibility, manufacturability and packaging design to allow biopharmaceutical companies to proactively and strategically streamline their clinical to commercial process and ultimately improve patient outcomes. https://lnkd.in/gA2uz2vR #PatientCentricity #AutoInjectors #CDMO #LetsTalkFuture

Jeff Clement recently spoke with Susan Haigney from Pharmaceutical Technology before the 2024 Bio International Convention on incorporating robotics into aseptic manufacturing. They discussed the challenges and benefits of isolator robotic sterile filling based on PCI Pharma Services' experience and expertise at their clinical facilities in San Diego, California, "Using robotics in sterile fill-finish operations provides hands-off aseptic manufacturing…no human interaction with the equipment is great for removing cross-contamination." To learn more on how isolator robotic sterile fill-finish platforms can provide enhanced sterility and quality assurance for your drug product, watch the full interview here:  Robotics in Sterile Processing https://lnkd.in/g8K6S9QR

Major advancements in patient-centric drug delivery present challenges and opportunities in drug product development, manufacturing, device design, clinical trials, regulatory filing, and commercialization. Save your space at our upcoming free knowledge-sharing seminar supporting your patient-centric drug delivery development. Hear from PCI Pharma Services Jerome Detreille, William Welch & Justin Schroeder, and Ralf Kuenzi of Ypsomed AG, Martin Gabler of Körber Pharma, who will discuss the critical success factors required to ensure the success of injectable products throughout their lifecycle. Be sure to stay for our buffet dinner and social networking event! Date: Tuesday 18th June 2024 Basel Marriot Hotel Switzerland Seminar details and full agenda: https://lnkd.in/eae9YN5j #CDMO #BioTech #PatientCentricity #LetsTalkFuture